Momenta Pharmaceuticals, Inc. (MNTA)

[Double_Bagel]

Now that MNTA has two approved products doesn't it deserve a much higher valuation than say CHRS which doesn't have any approved drugs yet.

http://www.coherus.com/corporate-performance/

Right now MNTA only has a Market cap of about $150-200 million higher than MNTA. A few months ago CHRS had a much higher market cap than MNTA.

http://finance.yahoo.com/echarts?s=MNTA+Interactive#%7B%22range%22%3A%22ytd%22%2C%22scale%22%3A%22linear%22%2C%22comparisons%22%3A%7B%22CHRS%22%3A%7B%22color%22%3A%22%23cc0000%22%2C%22weight%22%3A1%7D%7D%7D

What was the reason for CHRS to shoot up from $15 to $33 earlier this year? Couldn't the same reasons (for why it shot up) apply to MNTA now and more so with an approved drug?

Also, is EPRS worth looking into at this low Market cap?

Thanks.